Publication:
Creatinine kinase isoenzyme-MB: A simple prognostic biomarker in patients with pulmonary embolism treated with thrombolytic therapy

dc.contributor.authorBozbay, Mehmet
dc.contributor.authorUyarel, Huseyin
dc.contributor.authorAvsar, Sahin
dc.contributor.authorOz, Ahmet
dc.contributor.authorKeskin, Muhammed
dc.contributor.authorTanik, Veysel Ozan
dc.contributor.authorBakhshaliyev, NIJAD
dc.contributor.authorUgur, Murat
dc.contributor.authorPehlivanoglu, Seckin
dc.contributor.authorEren, Mehmet
dc.contributor.institutionauthorBAKHSALIYEV, NIJAD
dc.date.accessioned2021-01-16T20:59:19Z
dc.date.available2021-01-16T20:59:19Z
dc.date.issued2015-12-01T00:00:00Z
dc.description.abstractBackground: Creatinine kinase isoenzyme-MB(CK-MB) is a biomarker for detecting myocardial injury. The aim of this study was to evaluate the association between admission CK-MB levels and in-hospital and long-term clinical outcomes in pulmonary embolism(PE) patients treated with thrombolytic tissue-plasminogen activator.
dc.identifier.citationBozbay M., Uyarel H., Avsar S., Oz A., Keskin M., Tanik V. O. , Bakhshaliyev N., Ugur M., Pehlivanoglu S., Eren M., -Creatinine kinase isoenzyme-MB: A simple prognostic biomarker in patients with pulmonary embolism treated with thrombolytic therapy-, JOURNAL OF CRITICAL CARE, cilt.30, ss.1179-1183, 2015
dc.identifier.doi10.1016/j.jcrc.2015.07.014
dc.identifier.pubmed26296281
dc.identifier.scopus84947017953
dc.identifier.urihttp://hdl.handle.net/20.500.12645/27924
dc.identifier.wosWOS:000363945900006
dc.titleCreatinine kinase isoenzyme-MB: A simple prognostic biomarker in patients with pulmonary embolism treated with thrombolytic therapy
dc.typeArticle
dspace.entity.typePublication
local.avesis.idea7f428e-4cbf-4f82-b276-9aa8de12d13e
local.indexed.atPubMed
local.indexed.atWOS
local.indexed.atScopus
local.publication.isinternational1
relation.isAuthorOfPublicationd09a7383-b5b4-4454-aed7-bfa2b095b670
relation.isAuthorOfPublication.latestForDiscoveryd09a7383-b5b4-4454-aed7-bfa2b095b670

Files